Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric tadalafil versus placebo in pulmonary arterial hypertension
NL-OMON41448Phase 3Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tadalafil in pulmonary arterial hypertension (PAH), sponsored by Eli Lilly and Company. Started Mar 2014; status: active, not recruiting.
02
Drugs
tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NL-OMON41448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41448.